Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
7.85
-0.16 (-2.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Acrivon Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 243 | 109 | 241 | - | - |
| Market Cap Growth | -36.98% | -54.61% | - | - | - |
| Enterprise Value | 72 | -28 | 291 | - | - |
| Last Close Price | 8.01 | 4.92 | 11.52 | - | - |
| PE Ratio | - | -1.80 | -1.52 | - | - |
| PB Ratio | 1.15 | 0.90 | 1.41 | - | - |
| P/FCF Ratio | -3.24 | -2.49 | -7.45 | - | - |
| P/OCF Ratio | -3.37 | -2.56 | -7.99 | - | - |
| EV/EBITDA Ratio | -0.97 | 0.43 | -9.02 | - | - |
| EV/EBIT Ratio | -0.96 | 0.42 | -8.92 | - | - |
| EV/FCF Ratio | -1.33 | 0.65 | -9.03 | - | - |
| Debt / Equity Ratio | 0.02 | 0.04 | 0.03 | 0.06 | 0.04 |
| Debt / FCF Ratio | -0.08 | -0.11 | -0.15 | -0.40 | -0.02 |
| Quick Ratio | 16.00 | 9.58 | 19.61 | 34.18 | 2.58 |
| Current Ratio | 16.16 | 9.75 | 20.27 | 34.46 | 2.80 |
| Return on Equity (ROE) | -37.78% | -41.41% | -23.16% | -32.39% | - |
| Return on Assets (ROA) | -24.41% | -26.25% | -14.18% | -18.60% | - |
| Return on Capital (ROIC) | -25.50% | -27.84% | -14.59% | -19.09% | - |
| Earnings Yield | -27.81% | -55.30% | -12.95% | - | - |
| FCF Yield | -22.27% | -40.23% | -13.42% | - | - |
| Buyback Yield / Dilution | -81.46% | -435.63% | -136.43% | -21.70% | - |
| Total Shareholder Return | -81.46% | -435.63% | -136.43% | -21.70% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.